Unknown

Dataset Information

0

Neoantigen personalized vaccine plus anti-PD-1 antibody in cancer patients.

ABSTRACT:

SUBMITTER: Gonzalez-Cao M 

PROVIDER: S-EPMC9843347 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Neoantigen personalized vaccine plus anti-PD-1 antibody in cancer patients.

González-Cao María M   Rosell Rafael R  

Annals of translational medicine 20221201 24

Similar Datasets

Unknown Personalized neoantigen vaccine enhances the therapeutic efficacy of bevacizumab and anti-PD-1 antibody in advanced non-small cell lung cancer.
| S-EPMC10821847 | biostudies-literature
Unknown Combined TCR Repertoire Profiles and Blood Cell Phenotypes Predict Melanoma Patient Response to Personalized Neoantigen Therapy plus Anti-PD-1.
| S-EPMC7691446 | biostudies-literature
Unknown Botensilimab (Fc-enhanced anti-CTLA-4 antibody) plus balstilimab (anti-PD-1 antibody) in patients with treatment-refractory ovarian cancer.
| S-EPMC12730848 | biostudies-literature
Unknown Personalized neoantigen pulsed dendritic cell vaccine for advanced lung cancer.
| S-EPMC7817684 | biostudies-literature
Unknown Neoantigen landscape supports feasibility of personalized cancer vaccine for follicular lymphoma.
| S-EPMC11339042 | biostudies-literature
Unknown Neoantigen Vaccine Delivery for Personalized Anticancer Immunotherapy.
| S-EPMC6036114 | biostudies-literature
Unknown Neoantigen cancer vaccine augments anti-CTLA-4 efficacy.
| S-EPMC8810847 | biostudies-literature
Unknown Durable complete response to neoantigen-loaded dendritic-cell vaccine following anti-PD-1 therapy in metastatic gastric cancer.
| S-EPMC9166775 | biostudies-literature
Unknown Personalized neoantigen vaccine prevents postoperative recurrence in hepatocellular carcinoma patients with vascular invasion.
| S-EPMC8667400 | biostudies-literature
Unknown Mathematical model of a personalized neoantigen cancer vaccine and the human immune system.
| S-EPMC8462726 | biostudies-literature